Articles from Angelini Pharma; Catalyst Pharmaceuticals

Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
An earlier release was issued which has now been corrected.
By Angelini Pharma; Catalyst Pharmaceuticals · Via GlobeNewswire · May 7, 2026